Sirios Capital Management’s Allergan plc AGN Stock Holding History

Sirios Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-546,993	Closed	-$126M	–	47
2016 Q3	$126M	Sell	546,993 -289,607	-35%	-$70.8M	7.03%	2
2016 Q2	$193M	Buy	836,600 +165,094	+25%	+$38.1M	9.28%	1
2016 Q1	$180M	Sell	671,506 -18,812	-3%	-$5.39M	6.77%	3
2015 Q4	$216M	Buy	690,318 +155,036	+29%	+$46.2M	7.81%	2
2015 Q3	$145M	Buy	535,282 +216,340	+68%	+$66.5M	4.77%	4
2015 Q2	$96.8M	Buy	318,942 +142,025	+80%	+$42.4M	3.2%	10
2015 Q1	$52.7M	Buy	176,917 +117,107	+196%	+$33.4M	1.94%	23
2014 Q4	$15.4M	Buy	+59,810	New	+$14.9M	0.56%	37

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sirios Capital Management's AGN Position: Q4 2016 in Review

Sirios Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 546,993 shares — an estimated $126M sold.

Sirios Capital Management first reported a position in AGN in Q4 2014 and held it in 8 quarters. The position peaked at $216M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

Sirios Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
Sirios Capital Management sold 546,993 Allergan plc shares in Q4 2016, an estimated $126M.
Sirios Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 8 quarters.
Sirios Capital Management's Allergan plc position peaked at $216M in Q4 2015.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Sirios Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.